N-(4-methyl-1,3-thiazol-2-yl)-2-({2-oxo-1-[(pyridin-4-yl)methyl]-1H,2H,5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide structure
|
Common Name | N-(4-methyl-1,3-thiazol-2-yl)-2-({2-oxo-1-[(pyridin-4-yl)methyl]-1H,2H,5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide | ||
|---|---|---|---|---|
| CAS Number | 896366-36-2 | Molecular Weight | 413.5 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H19N5O2S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-(4-methyl-1,3-thiazol-2-yl)-2-({2-oxo-1-[(pyridin-4-yl)methyl]-1H,2H,5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide |
|---|
| Molecular Formula | C19H19N5O2S2 |
|---|---|
| Molecular Weight | 413.5 |
| InChIKey | LEIPFBVKISXWAJ-UHFFFAOYSA-N |
| SMILES | CC1=CSC(=N1)NC(=O)CSC2=NC(=O)N(C3=C2CCC3)CC4=CC=NC=C4 |
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|